Long-term Disease-free Survival after Hepatic Metastasectomy for Urothelial Carcinoma of the Bladder: A Case Report and Review of the Literature
Nathan A. Brooks(Eli Lilly (United States)), James A. Brown(University of Iowa Health Care), Laila Dahmoush(University of Iowa)
Cited by 2
Related Papers
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190
Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors
|Journal of the American Chemical Society|2002|189
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
|Nature Reviews Urology|2021|154
Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
|Molecular Cancer Therapeutics|2013|121